Dopamine Reduction in the Substantia Nigra of Parkinson's Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging

Gröger, Adriane; Kolb, Rupert; Schäfer, Rita; Klose, Uwe

dc.contributor.author	Gröger, Adriane
dc.contributor.author	Kolb, Rupert
dc.contributor.author	Schäfer, Rita
dc.contributor.author	Klose, Uwe
dc.date.accessioned	2014-04-23T14:52:12Z
dc.date.available	2014-04-23T14:52:12Z
dc.date.issued	2014-01-08
dc.identifier.uri	http://hdl.handle.net/10900/51753
dc.language.iso	en	de_DE
dc.publisher	San Francisco : PLOS	de_DE
dc.relation.uri	http://dx.doi.org/10.1371/journal.pone.0084081	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	magnetic resonance spectroscopic imaging	de_DE
dc.subject	metabolic change	de_DE
dc.subject	LCModel	de_DE
dc.subject	Parkinson's disease	de_DE
dc.subject	non-invasive	de_DE
dc.subject.classification	Dopamin , Substantia nigra , In vivo	de_DE
dc.subject.ddc	610	de_DE
dc.title	Dopamine Reduction in the Substantia Nigra of Parkinson's Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	1-6	de_DE
utue.personen.roh	Gröger, Adriane
utue.personen.roh	Kolb, Rupert
utue.personen.roh	Schäfer, Rita
utue.personen.roh	Klose, Uwe
dcterms.isPartOf.ZSTitelID	PLOS ONE	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	9	de_DE